{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih475ttfz37siq6xci3yvfogub2xoqzgszpx6c3swf7yrqj4rlbha",
    "uri": "at://did:plc:svcthvzunxmjidtlw23zva6n/app.bsky.feed.post/3mni25vsxed32"
  },
  "path": "/2026/06/04/era-congress-semaglutide-linked-to-better-quality-of-life-in-diabetes-and-kidney-disease-flow-trial-shows/",
  "publishedAt": "2026-06-03T22:01:00.000Z",
  "site": "https://laotiantimes.com",
  "tags": [
    "Cision PR Newswire"
  ],
  "textContent": "GLASGOW, Scotland, June 4, 2026 /PRNewswire/ — New findings from the landmark FLOW trial, presented at the 63rd ERA Congress, show that once-weekly semaglutide significantly improved health-related quality of life in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD), equivalent to around eight additional days in full health per year. The trial previously […]",
  "title": "ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows"
}